Locoregional therapy in de novo metastatic breast cancer: Systemic review and meta-analysis

CONCLUSIONS: LRT in de novo metastatic breast cancer is not associated with improved OS. Results are consistent among different breast cancer subgroups. However, this conclusion should be interpreted with caution in view of the limitations identified in meta-analysis.PMID:34158167 | DOI:10.1016/j.breast.2021.05.003

Source: Breast - June 23, 2021 Category: Cancer & Oncology Authors: Daniel Reinhorn Raz Mutai Rinat Yerushalmi Assaf Moore Eitan Amir Hadar Goldvaser Source Type: research